Alcoholic and Cocaine-Associated Cardiomyopathies

Progress in Cardiovascular Diseases

Volumn 52, Issue 4, 2010, Pages 289-299

  Awtry, Eric H ^a,b   Philippides, George J ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blockers; Alcohol; Cardiomyopathy; Cocaine; Heart failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; COCAINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLIC CARDIOMYOPATHY; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CLINICAL FEATURE; COCAINE DEPENDENCE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GENETIC SUSCEPTIBILITY; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LABORATORY DIAGNOSIS; LIFESTYLE MODIFICATION; LIVER FUNCTION TEST; LONG TERM CARE; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PROGNOSIS; RECIDIVISM; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; THROMBOGENESIS;

ADULT; AGED; ALCOHOLISM; ANIMALS; CARDIOMYOPATHIES; COCAINE-RELATED DISORDERS; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 73049098565     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.11.004     Document Type: Article

References (71)

1. Coate D. Moderate drinking and coronary heart disease mortality: evidence from NHANES I and the NHANES I Follow-up. Am J Public Health 83 (1993) 888-890
2. Kannel W.B., and Ellison R.C. Alcohol and coronary heart disease: the evidence for a protective effect. Clin Chim Acta 246 (1996) 59-76
3. Corrao G., Rubbiati L., Bagnardi V., et al. Alcohol and coronary heart disease: a meta-analysis. Addiction 95 (2000) 1505-1523
4. Mukamal K.J., Chiuve S.E., and Rimm E.B. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 166 (2006) 2145-2150
5. Rimm E.B., and Moats C. Alcohol and coronary heart disease: drinking patterns and mediators of effect. Ann Epidemiol 17 (2007) S3-S7
6. Collins M.A., Neafsey E.J., Mukamal K.J., et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 33 (2009) 206-219
7. Agarwal D.P. Cardiovascular effects of light-moderate consumption of alcohol: A review of putative mechanism. Alcohol and Alcoholism 37 (2002) 409-415
8. Di Castelnuovo A., Costanzo S., Bagnardi V., et al. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166 (2006) 2437-2445
9. Lazarevic' A.M., Nakatani S., Nes kovic A.N., et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol 35 (2000) 1599-1606
10. Gavazzi A., De Maria R., Parolini M., et al., on behalf of the Italian Multicenter Cardiomyopathy Study Group (SPIC). Alcohol abuse and dilated cardiomyopathy in men. Am J Cardiol 85 (2000) 1114-1118
11. Urbano-Marquez A., Estruch R., Navarro-Lopez F., et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320 (1989) 409-415
12. Vital and Health Statistics. Hyattsville, MD: U.S. Department of Health and Human Services. Centers for Disease Control and Prevention 13 (1995)
13. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data (2008), Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Georgia: U.S
14. Walsh C.R., Larson M.G., Evans J.C., et al. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 136 (2002) 181-191
15. Bryson C.L., Mukamal K.J., Mittleman M.A., et al. The association of alcohol consumption and incident heart failure. The Cardiovascular Health Study. J Am Coll Cardiol 48 (2006) 305-311
16. Djousse L., and Gaziano J.M. Alcohol consumption and risk of heart failure in the Physician's Health Study I. Circulation 115 (2007) 34-39
17. Djousse L., and Gaziano J.M. Alcohol consumption and heart failure in hypertensive US male physicians. Am J Cardiol 102 (2008) 593-597
18. Kupari M., Koskinen P., and Suokas A. Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics. Am J Cardiol 67 (1991) 274-279
19. Bertolet B.D., Freund G., Martin C.A., et al. Unrecognized left ventricular dysfunction in an apparently healthy alcohol abuse population. Drug Alcohol Depend 28 (1991) 113-119
20. Darcy M., Bland J.M., Leech G., et al. Preclinical left ventricular abnormalities in alcoholics are independent of nutritional status, cirrhosis, and cigarette smoking. Lancet 1 (1985) 1122-1125
21. McKenna C.J., Codd M.B., McCann H.A., et al. Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study. Am Heart J 135 (1998) 833-837
22. Dancy M., and Maxwell J.D. Alcohol and dilated cardiomyopathy. Alcohol Alcohol 21 (1986) 185-198
23. Urbano-Marquez A., Estruch R., Fernanez-Sola J., et al. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 274 (1995) 149-154
24. Piano M.R. Alcoholic cardiomyopathy: Incidence, clinical characteristics, and pathophysiology. Chest 121 (2002) 1638-1650
25. Matthews E.C., Gradin J.M., Henry W.L., et al. Echocardiographic abnormalities in chronic alcoholics with and without overt congestive heart failure. Am J Cardiol 47 (1981) 570-578
26. Fernández-Solà J., Estruch R., Nicolás J., et al. Comparison of Alcoholic Cardiomyopathy in Women Versus Men. Am J Cardiol 80 (1997) 481-485
27. Hibbs R.G., Ferrans V.J., Black W.C., et al. Alcoholic cardiomyopathy. An electron microscopic study. Am Heart J 69 (1965) 766-779
28. Ferrans V.J., Hibbs R.G., Weilbaecher D.G., et al. Alcoholic cardiomyopathy. A histochemical study. Am Heart J 69 (1965) 748-765
29. Lang R.M., Borow K.M., Neumann A., et al. Adverse effects of acute alcohol ingestion in young adults. Ann Intern Med 102 (1985) 742-747
30. Lang L.G., and Sobel B.E. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of alcohol. J Clin Invest 72 (1983) 724-731
31. 2+. Cell Mol Biol 45 (1999) 453-465
32. +transients in adult rat ventricular myocytes. Cell Mol Biol 43 (1997) 825-834
33. Schreiber S.S., Oratz M., and Rothschild M.A. Alcoholic cardiomyopathy: the effect of ethanol and acetaldehyde on cardiac protein synthesis. Recent Adv Stud Cardiac Struct Metab 7 (1975) 431-442
34. Li S., and Ren J. Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-included myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress. J Mol Cell Cardiol 44 (2008) 992-1001
35. Doser T.A., Turdi S., Thomas T., et al. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 119 (2009) 1941-1949
36. Cheng C.P., Cheng H.J., Cunningham C., et al. Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy. Circulation 114 (2006) 226-236
37. Fernandez-Sola J., Nicolas J.M., Oriola J., et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy. Ann Intern Med 137 (2002) 321-326
38. Wang L., Zhuo Z., Saari J., et al. Alcohol-induced myocardial fibrosis in metallothionein-null mice. Prevention by zinc supplementation. Am J Pathol 167 (2005) 337-344
39. Kesteloot H., Roelandt J., Willems J., et al. An inquiry into the role of cobalt in the heart disease of chronic beer drinkers. Circulation 37 (1968) 854-864
40. Fauchier L., Babuty D., Poret P., et al. Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 21 (2000) 306-314
41. Skotzko C.E., Vrinceanu A., Krueger L., et al. Alcohol use and congestive heart failure: indicence, importance, and approaches to improve history taking. Heart Fail Rev 14 (2009) 51-55
42. Kupari M., Koskinen P., Suokas A., et al. Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 66 (1990) 1473-1477
43. Kanjander O.A., Laippala P., Savolainen V., et al. Dose dependent but non-linear effects of alcohol on the left and right ventricle. Heart 86 (2001) 417-423
44. Prazak P., Pfisterer M., Osswald S., et al. Differences in disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 17 (1996) 251-257
45. Demakis J.G., Proskey A., Rahimtoola D.H., et al. The natural course of alcoholic cardiomyopathy. Ann Intern Med 80 (1974) 293-297
46. Hunt S.A., Abraham W.T., Chin M.H., et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 119 (2009) e391-e479
47. Guillo P., Mansourati J., Maheu B., et al. Long term prognosis of patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 79 (1997) 1276-1278
48. Nicolas J.M., Fernandez-Sola J., Estruch R., et al. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 136 (2002) 192-200
49. Cooper H.A., Exner D.V., and Domanski M.J. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000) 1753-1759
50. US Department of Health and Human Services: Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. September 2006.
51. Willens H., Chakko S., and Kessler K. Cardiovascular manifestations of cocaine abuse. A case of recurrent dilated cardiomyopathy. Chest 106 (1994) 594-600
52. Felker G., Hu W., and Hare J. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine 78 (1999) 270-283
53. Bertolet B., Freund G., and Martin D. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol 13 (1990) 323-328
54. Kloner R.A., Hale S., Alker K., et al. The effects of acute and chronic cocaine use on the heart. Circulation 85 (1992) 407-419
55. Mehta P., Grainger R., Lust R., et al. Effect of cocaine on left ventricular function: Relation to increased wall stress and persistence after treatment. Circulation 91 (1995) 3002-3009
56. Tazelaar H., Karch S., and Stephens B. Cocaine and the heart. Hum Pathol 18 (1987) 195-199
57. Virmani R., Robinowitz M., Smialek J., et al. Cardiovascular effects of cocaine: an autopsy study of 40 patients. Am Heart J 117 (1989) 1928-1929
58. Isabelle M., Vergeade A., Mortiz F., et al. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol 42 (2007) 326-332
59. Hollander J., Hoffman R., Burstein J., et al. Cocaine-associated myocardial infarction. Mortality and complications. Cocaine-Associated Myocardial Infarction Study Group. Arch Intern Med 155 (1995) 1081-1086
60. Mittleman M., Mintzer D., Maclure M., et al. Triggering of myocardial infarction by cocaine. Circulation 99 (1999) 2737-2741
61. Mccord J., Brody S., Slovis C., et al. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 88 (1990) 325-331
62. Sauer C. Recurrent embolic stroke and cocaine-related cardiomyopathy. Stroke 22 (1991) 1203-1205
63. Preston K., Epstein D., Cone E., et al. Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92 (1997) 717-727
64. Weiss R., and Gawin F. Protracted elimination of cocaine metabolites in long-term high dose cocaine abusers. Am J Med 85 (1988) 879-880
65. Gitter M., Goldsmith S., Dunbar D., et al. Cocaine and chest pain: clinical features and outcomes of patients hospitalized to rule out myocardial infarction. Ann Intern Med 115 (1991) 277-282
66. Brickner M., Willard J., Eichorn E., et al. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation 84 (1991) 1130-1135
67. McCord J., Jneid J., and Hollander J. Management of cocaine-associated chest pain and myocardial infarction. A scientific statement from the American Heart Association Acute Cardiac Care committee of the Council on Clinical Cardiology. Circulation 117 (2008) 1897-1907
68. Wilkerson R. Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomic and central nervous systems. J Pharmacol Exp Ther 246 (1988) 466-471
69. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 112 suppl IV (2005) IV-126-IV-132
70. Rappolt R., Gay G., Inaba D., et al. Propranolol in cocaine toxicity. Lancet 2 (1976) 640-641
71. Hollander J., Hoffman R., Gennis P., et al. Cocaine-associated chest pain: one year follow-up. Acad Emerg Med 2 (1995) 179-181